REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/09/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Kisuk Lee Harness, Dickey & Pierce, PLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical diagnostic reagents for immunization from disease; diagnostic test reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; reagents for use in medical genetic testing; in vitro diagnostic preparations for medical purposes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; reagents for use in veterinary genetic testing; antibodies for medical purposes; aptamers for medical purposes; diagnostic antibodies for medical purposes; diagnostic aptamers for medical purposes
Classe 10
Medical apparatus and instruments, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical apparatus and instruments other than for dental purposes, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; apparatus for use in medical analysis, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical genetic testing devices, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical instruments in the nature of genetic fragment analyzers; medical instruments in the nature of genetic material analyzers; medical absorption analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; DNA extraction and purification apparatus for medical purposes; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; body composition analyzers for medical purposes; body fluid analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; in vitro diagnostic devices, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical apparatus and instruments for DNA analysis, other than for dental purposes; medical apparatus and instruments for RNA analysis, other than for dental purposes; medical apparatus and instruments for protein analysis, other than for dental purposes; gene and genetic testing apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; cancer diagnosis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; diagnostic apparatus for medical purposes, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical body composition monitor; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; immunoassay apparatus for diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; miniaturized sensors for medical use in gene analysis and diagnosis; veterinary apparatus and instruments for DNA analysis; veterinary apparatus and instruments for RNA analysis; veterinary apparatus and instruments for protein analysis
Classe 44
Medical and healthcare services relating to DNA and genetics analysis and diagnosis and genetic testing; medical analysis services relating to the treatment of persons; physical examination services; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; medical analysis for the diagnosis and treatment of persons; RNA or DNA analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; genetic testing for medical purposes; provision of genetic testing for medical treatment purposes; provision of genetic information for medical treatment purposes; medical examination services; rental of medical machines and apparatus; rental of medical apparatus; performing medical diagnostic services involving medical testing and analysis for diagnostic and treatment purposes; medical testing services relating to the diagnosis and treatment of disease; Medical analysis services for the analysis of blood samples for diagnostic and treatment purposes provided by a medical laboratory; Medical analysis services for the analysis of samples taken from patients for diagnostic and treatment purposes provided by a medical laboratory; Medical analysis services for the analysis of blood samples taken from patients for diagnostic and treatment purposes provided by a medical laboratory
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/09/2025
FINAL DECISION TRANSACTION PROCESSED BY IB
06/02/2021
FINAL DISPOSITION NOTICE SENT TO IB
15/01/2021
FINAL DISPOSITION PROCESSED
15/01/2021
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/12/2020
REGISTERED-PRINCIPAL REGISTER
29/09/2020
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/08/2020
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/07/2020
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/07/2020
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/07/2020
PUBLISHED FOR OPPOSITION
14/07/2020
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/06/2020
APPROVED FOR PUB - PRINCIPAL REGISTER
10/06/2020
LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
28/10/2019
LETTER OF PROTEST EVIDENCE FORWARDED
17/10/2019
EXAMINER'S AMENDMENT ENTERED
25/09/2019
ASSIGNED TO LIE
24/09/2019
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
24/09/2019
EXAMINERS AMENDMENT E-MAILED
24/09/2019
EXAMINERS AMENDMENT -WRITTEN
24/09/2019
TEAS/EMAIL CORRESPONDENCE ENTERED
14/08/2019
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/08/2019
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/08/2019
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/07/2019
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/07/2019
REFUSAL PROCESSED BY IB
12/04/2019
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/03/2019
REFUSAL PROCESSED BY MPU
28/03/2019
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/03/2019
NON-FINAL ACTION WRITTEN
19/03/2019
ASSIGNED TO EXAMINER
08/03/2019
APPLICATION FILING RECEIPT MAILED
02/03/2019
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/02/2019
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/02/2019
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.